Acucela Secures Option to Exclusively License Novel Cataract Treatment

SEATTLE–(BUSINESS WIRE)–Acucela Inc. (Tokyo:4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, and YouHealth Eyetech, Inc. (“YouHealth”), announced today an agreement involving an exclusive option from YouHealth on lanosterol technology licensed from the Regents of the University of California, San Diego for the non-surgical pharmacologic treatme


Iris cysts may be associated with dissecting aortic aneurysms

PHILADELPHIA — A type of congenital iris cyst may be associated with life-threatening dissecting aortic aneurysms, a speaker said at the Wills Eye Alumni Conference here.Bilateral multifocal iris pigment epithelial cysts, also known as iris flocculi, may result from a shared genetic mutation in smooth muscle that affects the iris and aorta, Jerry A. Shields, MD, said.